Our mission is to improve the life of patients with cancers and autoimmune disorders by offering a safe, effective and affordable alternative to current second and third line therapies.

AAB Therapeutics develops precision biological drugs to treat cancer and autoimmune diseases, without the side effects of conventional chemotherapy. 

Our genetically programmable platform uses engineered extracellular vesicles (EVs) for drug delivery. These targeted nano-vesicles deliver therapeutic RNA directly to specific disease cells. This modular approach allows for rapid re-targeting to multiple, high-need indications, starting with liver/pancreatic cancer and autoimmunity.